These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37348495)

  • 21. In Silico Evaluation of Acetylation Mimics in the 27 Lysine Residues of Human Tau Protein.
    Kim YC; Jeong BH
    Curr Alzheimer Res; 2019; 16(5):379-387. PubMed ID: 30907318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging Trends in Cryo-EM-based Structural Studies of Neuropathological Amyloids.
    Mishra S
    J Mol Biol; 2023 Dec; 435(24):168361. PubMed ID: 37949311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
    Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
    Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.
    Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ
    J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
    Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
    J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryo-EM structure of RNA-induced tau fibrils reveals a small C-terminal core that may nucleate fibril formation.
    Abskharon R; Sawaya MR; Boyer DR; Cao Q; Nguyen BA; Cascio D; Eisenberg DS
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2119952119. PubMed ID: 35377792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling the Influence of K280 Acetylation on the Conformational Features of Tau Core Fragment: A Molecular Dynamics Simulation Study.
    Zou Y; Guan L
    Front Mol Biosci; 2021; 8():801577. PubMed ID: 34966788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies.
    Ramachandran G; Udgaonkar JB
    Biochemistry; 2013 Jun; 52(24):4107-26. PubMed ID: 23721410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Lys 280 → Gln mutation mimicking disease-linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties.
    Kumar H; Udgaonkar JB
    Protein Sci; 2021 Apr; 30(4):785-803. PubMed ID: 33496017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylation of Aβ42 at Lysine 16 Disrupts Amyloid Formation.
    Adhikari R; Yang M; Saikia N; Dutta C; Alharbi WFA; Shan Z; Pandey R; Tiwari A
    ACS Chem Neurosci; 2020 Apr; 11(8):1178-1191. PubMed ID: 32207962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chaperoning shape-shifting tau in disease.
    Ryder BD; Wydorski PM; Hou Z; Joachimiak LA
    Trends Biochem Sci; 2022 Apr; 47(4):301-313. PubMed ID: 35045944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States.
    Haj-Yahya M; Lashuel HA
    J Am Chem Soc; 2018 May; 140(21):6611-6621. PubMed ID: 29684271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cofactors are essential constituents of stable and seeding-active tau fibrils.
    Fichou Y; Lin Y; Rauch JN; Vigers M; Zeng Z; Srivastava M; Keller TJ; Freed JH; Kosik KS; Han S
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13234-13239. PubMed ID: 30538196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid-state NMR investigation of the involvement of the P2 region in tau amyloid fibrils.
    Savastano A; Jaipuria G; Andreas L; Mandelkow E; Zweckstetter M
    Sci Rep; 2020 Dec; 10(1):21210. PubMed ID: 33273615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tau P301L mutation promotes core 4R tauopathy fibril fold through near-surface water structuring and conformational rearrangement.
    Vigers MP; Lobo S; Najafi S; Dubose A; Tsay K; Ganguly P; Longhini AP; Jin Y; Buratto SK; Kosik KS; Shell MS; Shea JE; Han S
    bioRxiv; 2023 Nov; ():. PubMed ID: 38077065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between tau protein autoproteolysis and amyloid fibril formation.
    Ashrafi-Kooshk MR; Norouzi F; Zare Karizak A; Ahmadian S; Moosavi-Movahedi AA; Riazi G
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):129953. PubMed ID: 38325678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acetylation of tau inhibits its function and promotes pathological tau aggregation.
    Cohen TJ; Guo JL; Hurtado DE; Kwong LK; Mills IP; Trojanowski JQ; Lee VM
    Nat Commun; 2011; 2():252. PubMed ID: 21427723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations.
    Dong X; Qi R; Qiao Q; Li X; Li F; Wan J; Zhang Q; Wei G
    Phys Chem Chem Phys; 2021 Sep; 23(36):20406-20418. PubMed ID: 34494046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.